search
Back to results

Neuropsychological Evaluation of Psychiatric and Neurological Patients

Primary Purpose

Anxiety Disorder, Head Injury, Mood Disorder

Status
Completed
Phase
Locations
International
Study Type
Observational
Intervention
Sponsored by
National Institute of Mental Health (NIMH)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Anxiety Disorder focused on measuring Executive Functions, Language, Attention, Visual-Spatial Ability, Memory, Motor Behavior, Intelligence, Personality, Visual and Auditory Functioning, Hand and Eye Dominance, Normal Volunteer, Neuropsychiatric Disorders

Eligibility Criteria

undefined - 95 Years (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

INCLUSION CRITERIA: Patients. Normal volunteers. EXCLUSION CRITERIA: Subjects over 95 years of age. Subjects with a history of alcohol or drug abuse, psychopathology, or central nervous system pathology, other than that which defines group membership, may be excluded.

Sites / Locations

  • Childrens National Medical Center
  • National Institutes of Health Clinical Center, 9000 Rockville Pike
  • Henry Ford Health Systems
  • Mt. Sinai Medical Center
  • Columbia University
  • Genethon
  • Mosco Research Institute of Psychiatry

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
November 3, 1999
Last Updated
June 30, 2017
Sponsor
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT00001192
Brief Title
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Official Title
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Study Type
Observational

2. Study Status

Record Verification Date
December 20, 2006
Overall Recruitment Status
Completed
Study Start Date
October 18, 1983 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 20, 2006 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute of Mental Health (NIMH)

4. Oversight

5. Study Description

Brief Summary
This study will allow researchers to use various types of tests to evaluate cognitive and sensory functions. These tests, referred to as "batteries" will evaluate attention, executive functions, general intellectual functioning, language, memory, motor functions, orientation, personality, selected sensory and perceptual functions, vigilance (alertness), and visual-spatial functions. Children and adult patient will receive different test batteries. The goals of this research study are to; Create descriptions based on the performance of each patient on the test batteries. Then use this information to relate patient behavior to their neurophysiological, neuroradiological, and biochemical descriptions. Define subgroups of patients based on their neurobehavior in order to decrease the variability of psychiatric diagnoses, treatments, and prognoses.
Detailed Description
Neuropsychological tests are used to provide an assessment of cognitive functions in patients with idiopathic generalized epileptic (IGE) disorders and their first-degree relatives. The battery comprises tests designed to tap attention, memory, selected sensory and perceptual functions, vigilance, and visual-spatial functions. Modified batteries have been developed for the assessment of children ages 5-8, and children ages 8-16. The data provided by these batteries are compared with genetic profiles of the same participants that have been ascertained from blood samples analyzed by colleagues at the Mount Sinai School of Medicine/Columbia University in New York City.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Disorder, Head Injury, Mood Disorder, Schizophrenia, Seizures
Keywords
Executive Functions, Language, Attention, Visual-Spatial Ability, Memory, Motor Behavior, Intelligence, Personality, Visual and Auditory Functioning, Hand and Eye Dominance, Normal Volunteer, Neuropsychiatric Disorders

7. Study Design

Enrollment
4300 (false)

10. Eligibility

Sex
All
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
INCLUSION CRITERIA: Patients. Normal volunteers. EXCLUSION CRITERIA: Subjects over 95 years of age. Subjects with a history of alcohol or drug abuse, psychopathology, or central nervous system pathology, other than that which defines group membership, may be excluded.
Facility Information:
Facility Name
Childrens National Medical Center
City
Washington, D.C.
State/Province
District of Columbia
Country
United States
Facility Name
National Institutes of Health Clinical Center, 9000 Rockville Pike
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States
Facility Name
Henry Ford Health Systems
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
Facility Name
Mt. Sinai Medical Center
City
New York
State/Province
New York
ZIP/Postal Code
10029-0574
Country
United States
Facility Name
Columbia University
City
New York
State/Province
New York
ZIP/Postal Code
10032-3784
Country
United States
Facility Name
Genethon
City
Every Cedex
Country
France
Facility Name
Mosco Research Institute of Psychiatry
City
Moscow
Country
Russian Federation

12. IPD Sharing Statement

Citations:
PubMed Identifier
2727213
Citation
Johnstone EC, Owens DG, Bydder GM, Colter N, Crow TJ, Frith CD. The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychol Med. 1989 Feb;19(1):91-103. doi: 10.1017/s0033291700011053.
Results Reference
background

Learn more about this trial

Neuropsychological Evaluation of Psychiatric and Neurological Patients

We'll reach out to this number within 24 hrs